These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 37170239)

  • 21. When demand exceeds supply: Liver transplantation due to alcohol use disorder in Austria.
    Listabarth S; Gmeiner A; Pruckner N; Vyssoki S; Wippel A; König D
    Neuropsychiatr; 2020 Dec; 34(4):157-163. PubMed ID: 33141424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review.
    Odriozola A; Santos-Laso A; Del Barrio M; Cabezas J; Iruzubieta P; Arias-Loste MT; Rivas C; Duque JCR; Antón Á; Fábrega E; Crespo J
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Hospital Discharges with Alcohol-Related Liver Disease in a Gastroenterology and General Medical Unit Following the Introduction of Minimum Unit Pricing of Alcohol: The GRI Q4 Study.
    Chaudhary S; MacKey W; Duncan K; Forrest EH
    Alcohol Alcohol; 2022 Jul; 57(4):477-482. PubMed ID: 34343256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Universal screening for alcohol misuse in acute medical admissions is feasible and identifies patients at high risk of liver disease.
    Westwood G; Meredith P; Atkins S; Greengross P; Schmidt PE; Aspinall RJ
    J Hepatol; 2017 Sep; 67(3):559-567. PubMed ID: 28756907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
    Alberts CJ; Clifford GM; Georges D; Negro F; Lesi OA; Hutin YJ; de Martel C
    Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):724-735. PubMed ID: 35576953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
    Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
    PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.
    Riazi K; Azhari H; Charette JH; Underwood FE; King JA; Afshar EE; Swain MG; Congly SE; Kaplan GG; Shaheen AA
    Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):851-861. PubMed ID: 35798021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.
    Li J; Zou B; Yeo YH; Feng Y; Xie X; Lee DH; Fujii H; Wu Y; Kam LY; Ji F; Li X; Chien N; Wei M; Ogawa E; Zhao C; Wu X; Stave CD; Henry L; Barnett S; Takahashi H; Furusyo N; Eguchi Y; Hsu YC; Lee TY; Ren W; Qin C; Jun DW; Toyoda H; Wong VW; Cheung R; Zhu Q; Nguyen MH
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):389-398. PubMed ID: 30902670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
    Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of liver cirrhosis over ten consecutive years in Southern China.
    Wang X; Lin SX; Tao J; Wei XQ; Liu YT; Chen YM; Wu B
    World J Gastroenterol; 2014 Oct; 20(37):13546-55. PubMed ID: 25309085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elastic fibres in alcoholic liver disease.
    Luong TV; Abou-Beih S; Watkins J; Tsochatzis E; Pinzani M; Davison S; Hall A; Quaglia A
    Sci Rep; 2020 Nov; 10(1):20098. PubMed ID: 33208811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis.
    Liu J; Tian Y; Fu X; Mu C; Yao M; Ni Y; Liu Y; Li Z
    Chin Med J (Engl); 2022 Jul; 135(14):1682-1691. PubMed ID: 36070463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiological investigation of fatty liver disease in Northwest China].
    Yan H; Lu X; Gao Y; Luo J
    Zhonghua Gan Zang Bing Za Zhi; 2015 Aug; 23(8):622-7. PubMed ID: 26447628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AlcoChange: A digital therapeutic for patients with alcohol-related liver disease.
    Mehta G; Lin S; Nadar A; Pv B; Kumar R; Balaji A; Macdonald S; Sheikh MF; Saeidinejad M; Sharma SR; King JJ; Mookerjee RP; McDonagh L; Afuwape SA; Moore K; Jalan R
    JHEP Rep; 2024 Apr; 6(4):100993. PubMed ID: 38425452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethnicity matters: A Systematic Review and Meta-Analysis of the Non-Linear Relationship Between Alcohol Consumption and Prevalence and Incidence of Hepatic Steatosis.
    Roerecke M; Nanau R; Rehm J; Neuman M
    EBioMedicine; 2016 Jun; 8():317-330. PubMed ID: 27428441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
    Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
    Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and etiology of abnormal liver tests in an adult population in Jilin, China.
    Zhang H; He SM; Sun J; Wang C; Jiang YF; Gu Q; Feng XW; Du B; Wang W; Shi XD; Zhang SQ; Li WY; Niu JQ
    Int J Med Sci; 2011 Mar; 8(3):254-62. PubMed ID: 21487569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotinamide Adenine Dinucleotide Metabolome Is Functionally Depressed in Patients Undergoing Liver Transplantation for Alcohol-Related Liver Disease.
    Parker R; Schmidt MS; Cain O; Gunson B; Brenner C
    Hepatol Commun; 2020 Aug; 4(8):1183-1192. PubMed ID: 32766477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemic characteristics of alcohol-related liver disease in Asia from 2000 to 2020: A systematic review and meta-analysis.
    Xu H; Xiao P; Zhang F; Liu T; Gao Y
    Liver Int; 2022 Aug; 42(9):1991-1998. PubMed ID: 35593004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating myeloid populations have prognostic utility in alcohol-related liver disease.
    Khan R; Salman S; Harford L; Sheriff L; Hazeldine J; Rajoriya N; Newsome PN; Lalor PF
    Front Immunol; 2024; 15():1330536. PubMed ID: 38545104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.